Remediation of Emotional Processing Deficits in MS

Completed · Not applicable · Has a placebo group

Conditions studied: Multiple Sclerosis

In brief

This study will test the effectiveness of an emotional processing intervention in individuals with MS in a double blind placebo controlled randomized clinical trial. We will utilize an intervention which has been successfully used in other populations, including Schizophrenia and Traumatic Brain Injury. Our pilot data shows that this intervention is effective in individuals with MS as well

Key facts

Study ID

NCT03373344

Run by

Kessler Foundation

People needed

39

Starts

2016-11-01

Expected to finish

2020-03-01

Last updated by the study team

2020-07-10

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• between the ages of 18-65.
• diagnosis of Relapsing-Remitting Multiple Sclerosis.
• can read and speak English fluently.

You may not qualify if…

• history of prior stroke or other neurological disease or injury.
• history of significant psychiatric illness (for example, bipolar disorder, schizophrenia, or psychosis) or a current diagnosis of Major Depressive Disorder, Schizophrenia, Epilepsy, Bipolar Disorder.
• significant alcohol or drug abuse history.

Where it is running

• Kessler Foundation — East Hanover, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.